The Delhi High Court declines to stay the ongoing HPV immunisation campaign and instead directs the Centre to respond on the decision to introduce the vaccine. The court is hearing a public interest litigation that seeks a review of the HPV vaccination drive, with petitioners raising concerns about long-term safety, the adequacy of monitoring for adverse events, and whether individuals receive informed consent prior to vaccination. The court does not suspend the programme at this stage. It calls for clarity on the processes and protocols followed in rolling out the vaccine, and asks the Union government to provide its position and justification for the introduction of the HPV shots. The court also sets a timeline for the reply, requiring authorities to explain the matter within four weeks. The matter is listed for further hearing on October 29, where the court will review the response and determine next steps in the litigation.
Delhi High Court refuses to stay HPV vaccination drive, asks Centre for explanation
The Delhi High Court declines to stay the ongoing HPV immunisation campaign and instead directs the Centre to respond on the decision to introduce the vaccine. The court is hearing a public interest l...
- The Delhi High Court refuses to stay the HPV vaccination campaign.
- A public interest litigation challenges the vaccine’s introduction, citing long-term safety concerns.
- The petition raises issues about informed consent for recipients.
- The court asks the Centre to explain the decision and the protocols used to roll out the vaccine within four weeks.
- The case is scheduled for further hearing on October 29.
The Delhi High Court declined to halt the HPV immunisation campaign. Authorities must now explain the vaccine's introduction within four weeks. The court emphasized the need for proper protocols before administering vaccines. A Public Interest Litigation raised concerns about long-term safety and consent. The next hearing for this matter is scheduled for October 29.
3 hours agoThe court was hearing a public interest litigation seeking a review of the decision to introduce the HPV vaccine, raising concerns over its long-term safety, lack of informed consent, and monitoring of adverse events
4 hours ago
Salman Rushdie’s attacker faces federal terrorism trial after 2022 stabbing
A federal terrorism trial begins in Buffalo, New York, for Hadi Matar, the man convicted in a New York state attempted m...
Woman dies after cliff fall at Cornwall beauty spot, inquest opened
Rachel Anne Gwilliam, 41, dies in hospital in Plymouth after falling from cliffs at Pentreath Beach in Cornwall, accordi...
Pagasa reports LPAs bring rains; development prospects differ inside vs outside PAR
The Philippine Atmospheric, Geophysical and Astronomical Services Administration (Pagasa) reports two low-pressure area...